The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies
Zeineb Zian(Abdelmalek Essaâdi University), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Hamisu Abdullahi(Usmanu Danfodiyo University), Umair Ahmed Bargir(ICMR - National Institute of Immunohaemotology), Nazila Bahmaie(Near East University), Dana Ghotbi(Kharazmi University), Haroon Khan(Abdul Wali Khan University Mardan), S.P. Déo-Gracias Berry(Centre de Recherche Médicales de Lambaréné), Ali Kashif(Abdul Wali Khan University Mardan), Manisha Madkaikar(ICMR - National Institute of Immunohaemotology)
Cited by 10
Related Papers
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Primary immunodeficiency and autoimmunity: A comprehensive review
|Journal of Autoimmunity|2019|239